Does RIBOCICLIB Cause Pulmonary mass? 189 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 189 reports of Pulmonary mass have been filed in association with RIBOCICLIB (KISQALI). This represents 0.7% of all adverse event reports for RIBOCICLIB.
189
Reports of Pulmonary mass with RIBOCICLIB
0.7%
of all RIBOCICLIB reports
17
Deaths
42
Hospitalizations
How Dangerous Is Pulmonary mass From RIBOCICLIB?
Of the 189 reports, 17 (9.0%) resulted in death, 42 (22.2%) required hospitalization, and 9 (4.8%) were considered life-threatening.
Is Pulmonary mass Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 189 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Pulmonary mass?
ADALIMUMAB (1,299)
METHOTREXATE (1,153)
PREDNISONE (755)
ALBUTEROL (736)
ETANERCEPT (665)
TIOTROPIUM (624)
RITUXIMAB (531)
BUDESONIDE\FORMOTEROL (464)
MEPOLIZUMAB (450)
LEFLUNOMIDE (430)
Which RIBOCICLIB Alternatives Have Lower Pulmonary mass Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN